Introduction

This page provides a comprehensive analysis of the known insider trading history of Michael Grobstein. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Michael Grobstein has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:BMY / Bristol-Myers Squibb Company Director 87,898
US:MJN / Mead Johnson Nutrition Co. Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Michael Grobstein. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Michael Grobstein as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2020-07-02 2020-06-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 114 87,898 0.13 58.80 6,731 5,168,414
2020-04-02 2020-03-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 314 87,133 0.36 55.74 17,500 4,856,796
2020-02-04 2020-02-01 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 3,018 86,819 3.60 62.95 190,000 5,465,262
2020-01-03 2019-12-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 273 83,212 0.33 64.19 17,500 5,341,370
2019-10-02 2019-09-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 345 82,349 0.42 50.71 17,500 4,175,896
2019-07-02 2019-06-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 386 81,266 0.48 45.35 17,500 3,685,428
2019-04-02 2019-03-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 367 80,175 0.46 47.71 17,500 3,825,136
2019-02-05 2019-02-01 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 3,708 79,808 4.87 49.89 185,000 3,981,618
2019-01-03 2018-12-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 337 74,412 0.45 51.98 17,500 3,867,946
2018-10-02 2018-09-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 282 74,076 0.38 62.08 17,500 4,598,609
2018-07-03 2018-06-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 316 73,794 0.43 55.34 17,500 4,083,740
2018-04-03 2018-03-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 277 72,924 0.38 63.25 17,500 4,612,430
2018-02-05 2018-02-01 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 2,946 72,647 4.23 62.80 185,000 4,562,239
2018-01-03 2017-12-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 286 69,260 0.41 61.28 17,500 4,244,260
2017-10-03 2017-09-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 275 68,554 0.40 63.74 17,500 4,369,663
2017-07-05 2017-06-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 314 67,799 0.47 55.72 17,500 3,777,742
2017-06-15 2017-06-15 4 MJN Mead Johnson Nutrition Co
Restricted Stock Units
D - Sale to Issuer -1,709 0 -100.00 90.00 -153,810
2017-06-15 2017-06-15 4 MJN Mead Johnson Nutrition Co
Common Stock
D - Sale to Issuer -8,197 0 -100.00 90.00 -737,730
2017-04-04 2017-03-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 322 67,020 0.48 54.38 17,500 3,644,571
2017-03-02 2017-03-01 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise -2,373 0 -100.00
2017-03-02 2017-03-01 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 2,373 8,197 40.75
2017-03-02 2017-02-28 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
A - Award 1,709 1,709
2017-02-03 2017-02-01 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 3,449 66,699 5.45 49.29 170,000 3,287,575
2017-01-04 2016-12-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 299 62,753 0.48 58.44 17,500 3,667,292
2016-10-04 2016-09-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 325 61,990 0.53 53.92 17,500 3,342,499
2016-07-05 2016-06-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 232 61,359 0.38 73.55 17,060 4,512,982
2016-04-04 2016-03-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 254 60,806 0.42 63.88 16,250 3,884,308
2016-03-01 2016-02-29 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise 2,373 2,373
2016-03-01 2016-02-26 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise -1,678 0 -100.00
2016-03-01 2016-02-26 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 1,678 5,824 40.47
2016-02-03 2016-02-01 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 2,795 60,552 4.84 60.82 170,000 3,682,769
2016-01-05 2015-12-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 218 57,398 0.38 68.79 15,000 3,948,421
2015-10-02 2015-09-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 253 56,860 0.45 59.20 15,000 3,366,121
2015-07-29 2015-07-28 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 2,000 4,146 93.20 89.83 179,660 372,435
2015-07-01 2015-06-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 225 56,288 0.40 66.54 15,000 3,745,406
2015-04-02 2015-03-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 233 55,744 0.42 64.50 15,000 3,595,464
2015-03-03 2015-02-28 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise -2,146 0 -100.00
2015-03-03 2015-02-28 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 2,146 2,146
2015-02-27 2015-02-26 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
A - Award 1,678 1,678
2015-02-03 2015-02-01 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 2,655 55,511 5.02 60.27 160,000 3,345,652
2015-01-05 2014-12-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 252 52,534 0.48 59.55 15,000 3,128,378
2014-10-02 2014-09-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 291 51,960 0.56 51.55 15,000 2,678,516
2014-07-02 2014-06-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 307 51,302 0.60 48.83 15,000 2,505,062
2014-04-02 2014-03-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 288 50,626 0.57 52.00 15,000 2,632,534
2014-03-03 2014-02-28 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
A - Award 2,146 2,146
2014-02-04 2014-02-01 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 3,192 49,996 6.82 50.12 159,983 2,505,813
2014-01-02 2013-12-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 283 46,804 0.61 52.99 15,000 2,480,158
2013-10-02 2013-09-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 325 46,215 0.71 46.12 15,000 2,131,423
2013-07-02 2013-06-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 329 45,526 0.73 45.61 15,000 2,076,445
2013-04-02 2013-03-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 366 44,800 0.82 41.03 15,000 1,838,159
2013-02-05 2013-02-01 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 4,364 44,435 10.89 36.66 159,984 1,628,979
2013-01-03 2012-12-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 310 39,692 0.79 32.45 10,062 1,288,000
2012-10-02 2012-09-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 298 38,988 0.77 33.76 10,063 1,316,228
2012-07-03 2012-06-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 291 38,325 0.76 35.63 10,354 1,365,536
2012-04-03 2012-03-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 324 37,653 0.87 33.75 10,937 1,270,805
2012-02-03 2012-02-01 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 4,313 37,329 13.06 32.46 140,000 1,211,713
2012-01-04 2011-12-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 221 32,674 0.68 35.33 7,813 1,154,378
2011-10-04 2011-09-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 249 32,115 0.78
2007-04-03 2007-03-30 4 (BMY) BRISTOL MYERS SQUIBB CO
Deferred Share Units
A - Award 35 35
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)